LuciCer 150mg (Ceritinib)

Description

LuciCer 150mg (Ceritinib) is a targeted cancer medicine used to treat ALK-positive metastatic non-small cell lung cancer (NSCLC). It works by blocking the abnormal ALK protein, which helps slow or stop the growth of cancer cells.

Dosage:
The usual adult dose of LuciCer 150mg (Ceritinib) is 450 mg once daily with food, taken at the same time each day or as directed by a healthcare professional. Treatment typically continues until disease progression or unacceptable side effects occur.

Side Effects

Some patients using LuciCer 150mg (Ceritinib) may experience:

• Nausea
• Diarrhea
• Fatigue
• Loss of appetite
• Abdominal discomfort

In rare cases, LuciCer 150mg may cause serious side effects such as liver problems, lung inflammation, heart rhythm changes, or high blood sugar. Patients should contact a doctor if severe symptoms occur.

Prescribing Information

Before starting treatment, doctors usually confirm the ALK gene mutation through diagnostic testing. LuciCer 150mg (Ceritinib) should only be used under the supervision of an experienced healthcare professional.

Patients should inform their doctor about other medications and avoid using LuciCer 150mg during pregnancy or breastfeeding.

Suggestion

For best results, take LuciCer 150mg (Ceritinib) exactly as prescribed. Do not change the dose or stop treatment without medical advice. Regular monitoring and medical checkups are recommended during treatment.

FAQ

What is LuciCer 150mg (Ceritinib) used for?
It is used to treat ALK-positive non-small cell lung cancer (NSCLC).

How does LuciCer 150mg work?
LuciCer 150mg (Ceritinib) blocks the abnormal ALK protein, helping slow cancer cell growth.

How should LuciCer 150mg be taken?
It is usually taken once daily with food, as prescribed by a doctor.